Optimizing the sequencing of adjuvant chemotherapy and radiotherapy for early breast cancer
Rajiv Sarin* and Rakesh Jalali
Correspondence *Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Khargar, Navi Mumbai 410208 India
Email rsarin@actrec.res.in
This article has no abstract so we have provided the first paragraph of the full text.
Optimal sequencing of adjuvant CT and RT in the management of early breast cancer has been controversial. Since anthracycline-based CT administered concurrently with RT results in unacceptable severe toxicity,1 the universal practice is to administer CT first and RT second. This sequence is unlikely to be changed unless new compelling evidence suggests otherwise.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.